-
Signature
-
/s/ Kathleen Lenox, attorney-in-fact
-
Stock symbol
-
BKV
-
Transactions as of
-
May 1, 2025
-
Transactions value $
-
-$79,097
-
Form type
-
4
-
Date filed
-
5/2/2025, 12:00 PM
Reporting Owners (1)
Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
Tameron David |
Chief Financial Officer |
1200 17TH STREET, SUITE 2100, DENVER |
/s/ Kathleen Lenox, attorney-in-fact |
2025-05-02 |
0001954214 |
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BKV |
Common Stock |
Sale |
-$79.1K |
-4.41K |
-9.23% |
$17.94 |
43.4K |
May 1, 2025 |
Direct |
F1 |
holding |
BKV |
Common Stock |
|
|
|
|
|
300 |
May 1, 2025 |
By Son |
|
holding |
BKV |
Common Stock |
|
|
|
|
|
300 |
May 1, 2025 |
By Son |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: